Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment
ILMFCMHRDPDR
1 other identifier
interventional
10
1 country
1
Brief Summary
Purpose: To evaluate the logical surgical approaches in closing macular holes in eyes of proliferative diabetic retinopathy with retinal detachment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2018
CompletedFirst Submitted
Initial submission to the registry
July 23, 2018
CompletedFirst Posted
Study publicly available on registry
August 7, 2018
CompletedAugust 8, 2018
August 1, 2018
3 months
July 23, 2018
August 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wilcoxon Sign-Rank test
A statistical comparison of average of two dependent samples
Baseline, 12 months.
Study Arms (1)
Patient accept surgery
OTHERProliferative diabetic retinopathy suffering from MH with RD who were treated with vitrectomy combined with inverted epiretinal ILM flap,inverted ILM flaps insertion techniques, or free ILM flaps.
Interventions
The ILM flap anchoring on the hole edge was inverted and covered the hole.Otherwise, temporal side ILM flap was used. However, if the risk of ILM flipping back was judged to be high, ILM insertion instead of ILM hole coverage was adopted.If the size of the ILM flaps was judged inadequate, the double ILM insertion technique was used, done by adding a piece of previously obtained free ILM flap on top of the inverted ILM tissue until they were securely in place.
Eligibility Criteria
You may qualify if:
- Patients were proliferative diabetic retinopathy suffering from MH with RD.
You may not qualify if:
- Patients were not proliferative diabetic retinopathy suffering from MH with RD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Changhua Christian Hospital
Changhua, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chen San-Ni, MD
Changhua Christian Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor
Study Record Dates
First Submitted
July 23, 2018
First Posted
August 7, 2018
Study Start
March 7, 2018
Primary Completion
May 31, 2018
Study Completion
July 15, 2018
Last Updated
August 8, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR